Clinical Trials · NCT00329043
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 64
- Start date
- May 2006
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants With Pathological Complete Response (pCR)